Skip to main content
SpringerLink
Log in

Pravachol [pravastatin] and Mevacor [lovastatin] have the best muscle-related safety profile of statins marketed in the US,

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. AdverseEvents Inc.Results of an Extensive Safety Review of the $19 Billion U.S. Statin Drug Class. Media Release: 20 Oct 2011. Available from: URL: http://www.adverseevents.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pravachol [pravastatin] and Mevacor [lovastatin] have the best muscle-related safety profile of statins marketed in the US,. React. Wkly. 1376, 3 (2011). https://doi.org/10.2165/00128415-201113760-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113760-00007

Keywords

Search

Navigation